Advances in the treatment of multiple myeloma

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.

Leukemia·2017

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.

Leukemia·2017

A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma.

Bone marrow transplantation·2017

A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma.

Therapeutic advances in hematology·2016

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma.

Clinical pharmacology and therapeutics·2016

Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients.

Bone marrow transplantation·2016

From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology.

Cancer treatment reviews·2026

Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges.

Cancer treatment reviews·2026

MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.

Cancer treatment reviews·2026

Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies.

Cancer treatment reviews·2026

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Cancer treatment reviews·2026

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Cancer treatment reviews·2026

Leveraging a Deep Learning Model and Computational Screening for the Discovery of ABCG2 Inhibitors against Drug-Resistant Breast Cancer.

Journal of chemical information and modeling·2026

Calcium phosphate nanoparticles carrying YAP plasmid promote osteogenic potential in dental pulp stem cells by modulating BMP-2 expression and macrophage M2-like phenotype.

Connective tissue research·2026

A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study.

Journal of comparative effectiveness research·2026

Research Progress of Traumatic Brain Injury and Its Related Markers.

Clinical laboratory·2026

Discovery of human antibody specific to the spike glycoprotein subunit 2 of SARS-CoV-2 and characterization of its broad-spectrum neutralizing activity.

Infectious medicine·2026

Single-cell vector copy number analysis of phenotypically defined long-term hematopoietic stem cells for gene therapy safety assessment.

Molecular therapy. Advances·2026

Related Experiment Videos

Advances in the treatment of multiple myeloma

Related Concept Videos

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.

A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma.

A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma.

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma.

Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients.

From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology.

Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges.

MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.

Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies.

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Leveraging a Deep Learning Model and Computational Screening for the Discovery of ABCG2 Inhibitors against Drug-Resistant Breast Cancer.

Calcium phosphate nanoparticles carrying YAP plasmid promote osteogenic potential in dental pulp stem cells by modulating BMP-2 expression and macrophage M2-like phenotype.

A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study.

Research Progress of Traumatic Brain Injury and Its Related Markers.

Discovery of human antibody specific to the spike glycoprotein subunit 2 of SARS-CoV-2 and characterization of its broad-spectrum neutralizing activity.

Single-cell vector copy number analysis of phenotypically defined long-term hematopoietic stem cells for gene therapy safety assessment.

Related Experiment Videos

Advances in the treatment of multiple myeloma

Related Concept Videos

Related Articles